The role of glial pathology in Huntington's disease

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

This review will focus on the contribution of glial pathology to HD, particularly so with regard to diseased glial progenitor cells and their derived astrocytes and oligodendrocytes. It will briefly discuss the body of data identifying the contribution of glial dysfunction to disease phenotype in rodent models of HD, and will then focus on recent studies of cell-intrinsic glial transcriptional dysregulation in HD. The review will emphasize recent studies of diseased human cells and humanized models of HD glial pathology, and on the contributions of that glial pathology to neuronal and synaptic dysfunction in HD.

Original languageEnglish
Title of host publicationHuntington's Disease : Pathogenic Mechanisms and Implications for Therapeutics
Number of pages15
PublisherElsevier
Publication date2024
Pages337-351
Chapter14
ISBN (Print)9780323956734
ISBN (Electronic)9780323956727
DOIs
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier Inc. All rights reserved.

    Research areas

  • Astrocytes, Glia, hESC, Huntington's disease, Myelin, OLIG2, Oligodendrocytes, Stem cell, TCF7L2

ID: 388544940